A comparative randomized, open-label, rater-blinded study of paliperidone palmitate and risperidone long-acting injectable therapy in patients with schizophrenia

被引：0
|
作者：
Li, H. [1 ]
Rui, Q.
Ning, X.
Xu, H.
Gu, N. [1 ]
机构：
[1] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [31] FLEXIBLY DOSED PALIPERIDONE PALMITATE IN NON-ACUTE BUT SYMPTOMATIC PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH LONG-ACTING INJECTABLE RISPERIDONE
    Schreiner, Andreas
    Bergmans, Paul
    Llorca, Pierre-Michel
    Corrivetti, Giulio
    Cosar, Behcet
    Cherubin, Pierre
    Hargarter, Ludger
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S363 - S363
  • [32] FLEXIBLY DOSED PALIPERIDONE PALMITATE IN NON-ACUTE BUT SYMPTOMATIC PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH LONG-ACTING INJECTABLE RISPERIDONE
    Schreiner, A.
    Bergmans, P.
    Llorca, P. M.
    Corrivetti, G.
    Cosar, B.
    Cherubin, P.
    Hargarter, L.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [33] Treatment of schizophrenia with long-acting injectable risperidone: A 12-month open-label trial of the first long-acting second-generation antipsychotic
    Fleischhacker, WW
    Eerdekens, M
    Karcher, K
    Remington, G
    Llorca, PM
    Chrzanowski, W
    Martin, S
    Gefvert, O
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (10) : 1250 - 1257
  • [34] FLEXIBLY DOSED PALIPERIDONE PALMITATE IN NON-ACUTE BUT SYMPTOMATIC PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH LONG-ACTING INJECTABLE RISPERIDONE
    Schreiner, A.
    Bergmans, P.
    Llorca, P-M
    Corrivetti, G.
    Cosar, B.
    Cherubin, P.
    Hargarter, L.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2014, 48 : 130 - 131
  • [35] Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan
    Mahlich, Jorg
    Nishi, Masamichi
    Saito, Yoshimichi
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 267 - 272
  • [36] A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia
    Taylor, Mark
    Huang, Hannah Chu-Han
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2017, 7 (10) : 231 - 233
  • [37] Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
    Such, Pedro
    Olivares, Jose Manuel
    Arias, Lizbeth
    Berg, Mette Troels
    Madera, Jessica
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1881 - 1892
  • [38] A RATER-BLINDED, RANDOMIZED, COMPARATIVE STUDY OF ARIPIPRAZOLE VERSUS BLONANSERIN IN JAPANESE PATIENTS WITH SCHIZOPHRENIA
    Mukai, Tomohiko
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S274 - S275
  • [39] Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients
    Verma, Swapna
    Subramaniam, Mythily
    Abdin, Edimansyah
    Sim, Kang
    Su, Alex
    Lee, Nelson
    Chong, Siow Ann
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (03) : 230 - 235
  • [40] TOLERABILITY AND EFFICACY OF PALIPERIDONE PALMITATE VS. RISPERIDONE LONG-ACTING THERAPY IN SUBJECTS WITH RECENTLY DIAGNOSED SCHIZOPHRENIA
    Sliwa, Jennifer Kern
    Bossie, Cynthia
    Fu, Dong Jing
    Ma, Y. M.
    Alphs, L.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 310 - 310
12345